Sirolimus for the treatment of complicated vascular anomalies in children.

نویسندگان

  • Adrienne M Hammill
  • MarySue Wentzel
  • Anita Gupta
  • Stephen Nelson
  • Anne Lucky
  • Ravi Elluru
  • Roshni Dasgupta
  • Richard G Azizkhan
  • Denise M Adams
چکیده

BACKGROUND Vascular anomalies comprise a diverse group of diagnoses. While infantile hemangiomas are common, the majority of these conditions are quite rare and have not been widely studied. Some of these lesions, though benign, can impair vital structures, be deforming, or even become life-threatening. Vascular tumors such as kaposiform hemangioendotheliomas (KHE) and complicated vascular malformations have proven particularly difficult to treat. PROCEDURE Here we retrospectively evaluate a series of six patients with complicated, life-threatening vascular anomalies who were treated with the mTOR inhibitor sirolimus for compassionate use at two centers after failing multiple other therapies. RESULTS These patients showed significant improvement in clinical status with tolerable side effects. CONCLUSIONS Sirolimus appears to be effective and safe in patients with life-threatening vascular anomalies and represents an important tool in treating these diseases. These findings are currently being further evaluated in a Phase II safety and efficacy trial.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Use of Oral Sirolimus in Paediatric Patients with Serious Vascular Anomalies: Case Report

Background Pediatric vascular anomalies comprise a heterogeneous group of clinical disorders of varying severity. These anomalies are divided into vascular tumors or vascular malformations. Different therapeutic strategies have been used depending on the pathology in question. In recent years, mammalian target of rapamycin (mTOR) inhibitors have been explored as a therapeutic option in patients...

متن کامل

Efficacy and Safety of Mammalian Target of Rapamycin Inhibitors in Vascular Anomalies: A Systematic Review.

Mammalian target of rapamycin (mTOR) inhibitors are a promising new treatment in vascular anomalies, but no published randomized controlled trials are available. The aim of this systematic review of all reported cases was to assess the efficacy and safety of mTOR inhibitors in all vascular anomalies, except cancers, in children and adults. In November 2014 MEDLINE, CENTRAL, LILACS and EMBASE we...

متن کامل

A Survey on dental anomalies among children with lip and palate clefts in Mashhad Dental School (2000)

A Survey on dental anomalies among children with lip and palate clefts in Mashhad Dental School (2000) Dr. BM. Ajami * - Dr. M. Talebi ** * - Associate Professor of Pedodontics Dept. - Faculty of Dentistry – Mashhad University of Medical Sciences. ** - Assistant Professor of Pedodontics Dept. Faculty of Dentistry – Mashhad University of Medical Sciences. Background and Aim: Children born with l...

متن کامل

Dental Anomalies and Dental Age Assessment in Treated Children with Acute Lymphoblastic Leukemia

Background This cross sectional study was performed to evaluate dental ages and incidence of dental anomalies in children treated for acute lymphoblastic leukemia (ALL). Methods and materials A total of 25 ALL patient who passed at least 2 years of chemotherapy and 25 healthy sex and age matched children were evaluated. Dental age as well as dental anomalies in shape, size, number, and s...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Pediatric blood & cancer

دوره 57 6  شماره 

صفحات  -

تاریخ انتشار 2011